21 September 2020
Medicine Compliance Aid Stability
De-NoltabAstellas Pharma Ltd
Astellas Pharma Ltd
R1 · Red 1 Stability data indicates that the drug is not suitable for CAs.
Complex administration schedule makes this drug unsuitable for inclusion in MCA.
4 November 2015
Lactation Safety Information
No published evidence of safety
Minimal GI absorption by the mother and infant
Used in infants >1 month
11 July 2016